Castleark Management’s OrthoPediatrics KIDS Stock Holding History

Castleark Management’s Portfolio KIDS Stock Details KIDS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-37,915	Closed	-$2.05M	–	325
2022 Q1	$2.05M	Buy	37,915 +270	+0.7%	+$13.8K	0.09%	189
2021 Q4	$2.25M	Sell	37,645 -33,890	-47%	-$2.11M	0.08%	183
2021 Q3	$4.69M	Buy	+71,535	New	+$4.65M	0.18%	130

Other funds holding KIDS

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

NCGI

Next Century Growth Investors Plymouth, Minnesota $1.38B AUM 102.34% 1-Year Est. Return

DDC

DF Dent & Co Baltimore, Maryland $5.22B AUM 2.07% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return

Castleark Management's KIDS Position: Q2 2022 in Review

Castleark Management sold out of OrthoPediatrics (KIDS) in Q2 2022, closing a stake of 37,915 shares — an estimated $2.05M sold.

Castleark Management first reported a position in KIDS in Q3 2021 and held it in 3 quarters. The position peaked at $4.69M in Q3 2021. 117 funds tracked by Wall St. Rank hold KIDS as of Q2 2022.

Castleark Management reported no remaining OrthoPediatrics position as of Q2 2022 after selling out during the quarter.
Castleark Management sold 37,915 OrthoPediatrics shares in Q2 2022, an estimated $2.05M.
Castleark Management first reported a position in OrthoPediatrics in Q3 2021 and held it in 3 quarters.
Castleark Management's OrthoPediatrics position peaked at $4.69M in Q3 2021.
117 funds tracked by Wall St. Rank held OrthoPediatrics as of Q2 2022.

Based on Castleark Management's 13F filing for Q2 2022, filed 16 Aug 2022.